HAIFA, Israel , August 13 /PRNewswire/ -- SCD has announced the receipt of a phase I contract from DARPA, valued at $1.75 million, for the development of a new "XBn" infrared detector technology. If ...
DENVER, April 08, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients ...
FDA approves SeaStar Medical's SCD-ADULT study for treating acute heart failure with renal issues, funded by a $3.6 million NIH grant. SeaStar Medical Holding Corporation announced that the U.S. FDA ...
Hosted on MSN
Cardinal Health launches new compression system
Cardinal Health has launched the Kendall SCD SmartFlow device in the US, the latest in the company’s series of compression systems to mitigate the risk of venous thromboembolism events (VTE) including ...
SeaStar Medical Holding Corporation (NASDAQ:ICU) shares are trading higher on Thursday, on continued strength after the company received FDA Breakthrough Device Designation for its cell-directed ...
Interim study data show that SCD treatment is safe to use in pediatric patients with Acute Kidney Injury (AKI) requiring continuous kidney replacement therapy (CKRT) The SCD is currently being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results